Lenvatinib for large hepatocellular carcinomas with portal trunk invasion: Two case reports

Figure 6 Time course of the serum alpha-fetoprotein and modified albumin–bilirubin score during chemotherapy in case 2. The serum alpha-fetoprotein level decreased to normal at 2 wk after the start of administration, with no apparent subsequent rise. The modified albumin–bilirubin score improved, after initial worsening for up to 2 wk after the start of lenvatinib administration but recovered to improve at 5 wk after the treatment. AFP: Alpha-fetoprotein; ALBI: Albumin–bilirubin.